Economic burden of interstitial lung disease in a commercially insured population with Sj√∂gren syndrome in the United States
========================================================================

<img src="https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg" alt="Study Status: Results Available"> 

- Analytics use case(s): **Population-Level Estimation** 
- Study type: **Cost of Illness** 
- Study lead: **Tsung-Ying Lee**
- Publications: https://www.jmcp.org/doi/epdf/10.18553/jmcp.2022.28.7.786

The objective of this study is to estimate the direct health care costs associated with ILD among patients with SjS in a representative sample of the commercially insured population in the United States.
